Categories Earnings Calls, Health Care

Johnson & Johnson (JNJ) Q2 2021 Earnings Call

Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021

Corporate Participants:

Christopher DelOrefice — Vice President, Investor Relations

Joseph J. Wolk — Executive Vice President, Chief Financial Officer

Jennifer Taubert — Executive Vice President, Worldwide Chairman, Pharmaceuticals

Thibaut Mongon — Executive Vice President, Worldwide Chairman, Consumer Health

Ashley McEvoy — Executive Vice President, Worldwide Chairman, Medical Devices

Paul Stoffels — Vice Chairman of the Executive Committee and Chief Scientific Officer

Analysts:

Louise Chen — Cantor Fitzgerald Securities — Analyst

Larry Biegelsen — Wells Fargo Securities LLC — Analyst

Chris Schott — J.P. Morgan Securities LLC — Analyst

Bob Hopkins — BofA Securities, Inc. — Analyst

Joshua Jennings — Cowen and Company — Analyst

Terence Flynn — Goldman Sachs & Co. LLC — Analyst

Matt Miksic — Credit Suisse Securities (USA) LLC — Analyst

Joanne Wuensch — Citi — Analyst

Jayson Bedford — Raymond James Financial Inc. — Analyst

_________

To read the full earnings call transcript, click here

Most Popular

AAPL Earnings: Apple’s Q2 sales and profit beat estimates; iPhone sales down 10%

Apple Inc. (NASDAQ: AAPL) on Thursday reported better-than-expected profit and revenue for the second quarter of 2024. There was a 10% decrease in iPhone sales. The gadget giant reported revenues

Shopify (SHOP) is all set to report Q1 2024 results. Here’s what to expect

Over the years, Shopify Inc. (NYSE: SHOP) has steadily expanded its footprint in the online retail market through constant innovation, like the recent launch of a mobile POS device for

eBay (EBAY): A look at how the ecommerce company fared in Q1 2024

Shares of eBay Inc. (NASDAQ: EBAY) were down over 2% on Thursday. The company reported its earnings results for the first quarter of 2024 a day ago, with revenue and

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top